Eastman Chemical Co. (EMN) Tops Q2 EPS by 14c; Guides Q3, FY11 EPS
Tweet
Share
E-mailGet Alerts EMN Hot Sheet
Price: $70.37 -1.15%
Revenue Growth %: +10.0%
Financial Fact:
Operating earnings: 356M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +10.0%
Financial Fact:
Operating earnings: 356M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Eastman Chemical Co. (NYSE: EMN) reported Q2 EPS of $2.76, $0.14 better than the analyst estimate of $2.62. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.81 billion.
Sees Q3 2011 EPS slightly better than $2.22, versus the consensus of $2.35.
Sees FY2011 EPS slightly better than $9.25, versus the consensus of $9.31.
Sees Q3 2011 EPS slightly better than $2.22, versus the consensus of $2.35.
Sees FY2011 EPS slightly better than $9.25, versus the consensus of $9.31.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- Solaris Energy raises 2026 guidance, initiates Q1 2027 outlook
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
